DME Capital Reduces Stake in Victoria's Secret Amid Strong Performance
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 14 2025
0mins
Should l Buy VSCO?
Victoria's Secret shares fell by 5.02% as the stock crossed below its 5-day SMA, reflecting broader market weakness with the Nasdaq-100 down 0.45% and the S&P 500 down 0.65%.
DME Capital recently sold 194,593 shares of Victoria's Secret for approximately $7.73 million, indicating a strategy to realize profits after a significant stock price increase. Despite this reduction, the value of DME Capital's stake in Victoria's Secret grew by $41.69 million, showcasing the company's strong market position with a reported $1.5 billion in sales for Q3 2025, a 9% year-over-year increase, and an increased full-year guidance to $6.5 billion.
The reduction in stake by DME Capital may raise concerns among investors, but the overall performance metrics indicate robust growth potential for Victoria's Secret in the competitive women's apparel market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy VSCO?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on VSCO
Wall Street analysts forecast VSCO stock price to fall
11 Analyst Rating
4 Buy
7 Hold
0 Sell
Moderate Buy
Current: 61.180
Low
29.00
Averages
53.40
High
73.00
Current: 61.180
Low
29.00
Averages
53.40
High
73.00
About VSCO
Victoria's Secret & Co. is a specialty retailer of women's intimate and other apparel and beauty products marketed under the Victoria's Secret, PINK, and Adore Me brand names. The Company offers a range of products including bras, panties, lingerie, casual sleepwear, apparel, sport and swim, as well as prestige fragrances and body care. Victoria’s Secret brand offers bras, panties, lingerie, casual sleepwear, swim, lounge and sport, as well as fragrances and body care. PINK is a lifestyle brand for young women providing variety of collections and heritage pieces, including apparel, loungewear, activewear, bras, panties, accessories, beauty, and others. Adore Me is a direct-to-consumer lingerie and apparel brand that is focused on serving women of all sizes and budgets.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Wall Street's First Trading Day of March Outlook
- Middle East Impact: The U.S.-Israeli attack on Iran is likely to ripple through financial markets, with oil prices rising due to geopolitical risk premiums, as Brent crude has surged from the low $60s to around $73, indicating potential for further volatility.
- CrowdStrike Earnings Preview: CrowdStrike is set to report its quarterly results after Tuesday's close, with Wall Street expecting fiscal 2026 Q4 revenue of $1.3 billion and EPS of $1.10, providing CEO George Kurtz an opportunity to highlight the cybersecurity sector's unique position amidst AI disruption fears.
- Broadcom Earnings Expectations: Broadcom will release its earnings on Wednesday, with anticipated fiscal 2026 Q1 revenue of $19.14 billion and EPS of $2.02, as market sentiment remains optimistic about AI chip demand despite concerns over potential disruptions to infrastructure software.
- Costco Quarterly Report: Costco is expected to report its fiscal 2026 Q2 results after Thursday's close, with projected revenue of $69.22 billion and EPS of $4.56, as management will address consumer spending trends and membership renewal rates amid high price pressures.
See More
DME Capital Reduces Stake in Victoria's Secret
- Share Reduction Details: According to an SEC filing dated February 17, 2026, DME Capital reduced its stake in Victoria's Secret by 194,593 shares during Q4 2025, with an estimated transaction value of $7.73 million, indicating a strategy to realize profits amid rising stock prices.
- Value Change in Holdings: Despite the reduction, Victoria's Secret still represented 3.3% of DME Capital's assets, with the stake's value increasing by $41.69 million due to trading activity and price performance, reflecting the company's strong market position.
- Performance Metrics: As of February 17, 2026, shares of Victoria's Secret were priced at $60.36, marking a 93.2% increase over the past year, significantly outperforming the S&P 500 by 71.94 percentage points, showcasing robust growth in the competitive women's apparel market.
- Future Outlook: Victoria's Secret reported $1.5 billion in sales for Q3 2025, a 9% year-over-year increase, and raised its full-year guidance to $6.5 billion, indicating continued growth potential, although the current price-to-earnings ratio exceeding 30 may affect investors' buying decisions.
See More
DME Capital Reduces Stake in Victoria's Secret
- Share Reduction Transaction: DME Capital sold 194,593 shares of Victoria's Secret in Q4 2025, with an estimated trade value of $7.73 million, reflecting the fund's strategy to realize profits following a stock price increase.
- Holding Value Growth: As of December 31, 2025, the value of DME Capital's stake in Victoria's Secret increased by $41.69 million, indicating the dual impact of trading activity and price performance, although the stock now represents 3.3% of the fund's assets.
- Performance Exceeds Expectations: Victoria's Secret reported $1.5 billion in sales for its fiscal Q3, a 9% year-over-year increase, and raised its full-year guidance to $6.5 billion, further driving the stock price upward.
- Market Performance Analysis: The stock price of Victoria's Secret surged by 93.2% over the past year, reaching a 52-week high of $66.89 on January 9, 2026, demonstrating its strong performance in the highly competitive women's apparel market.
See More
Market Strategist Highlights Key Stock Picks
- Victoria's Secret Outlook: Market strategist highlights Victoria's Secret (VSCO) as performing well in the current bullish trend, with support at $55 to $58; if it breaks through recent highs of $62 to $63, it could reach new all-time highs, indicating strong potential driven by consumer confidence and diet drugs.
- Novo Nordisk Competitive Pressure: Novo Nordisk (NVO) faces competition from other pharmaceutical companies, and while its stock is under pressure around $47.73, analysts believe that if it can rebound to $50 to $52, the bottom support will appear solid, maintaining a long-term bullish outlook.
- BitMine Market Opportunity: BitMine (BMNR) is viewed as a stock play on cryptocurrency, with analysts optimistic about Ethereum's prospects, considering it undervalued; if it can hold around $1,900 and break above $2,000, significant upside potential may arise.
- Cryptocurrency Volatility: Despite recent volatility in the crypto market, analysts note that Ethereum's stability is improving, and sustained buying interest could make BMNR a key asset in their portfolio, reflecting confidence in the future of the crypto market.
See More
Trump Aims to Reinforce Tariffs Following Court Loss: Implications for the Economy and Investors.
Market Reaction: Stocks experienced a rally on Friday following the Supreme Court's rejection of a key aspect of President Trump's trade policy.
Future Outlook: Despite the initial market relief, investors are advised to brace for upcoming economic uncertainties.
See More
Seldon Capital Acquires Stake in Victoria's Secret & Co.
- New Investment Disclosure: Seldon Capital disclosed the acquisition of 155,950 shares of Victoria's Secret in Q4 2025, amounting to approximately $8.45 million, marking a new investment that reflects confidence in the brand's future growth potential.
- Significant Stake: This acquisition gives Seldon Capital a 2.92% stake in Victoria's Secret, representing a notable position within its reportable U.S. equity AUM, indicating a bullish outlook on the consumer goods sector.
- Performance Rebound: Victoria's Secret recently reported Q3 net sales of $1.472 billion, up 9% year-over-year, with management raising full-year sales guidance to $6.48 billion, showcasing strong performance amid market recovery.
- Enhanced Market Competitiveness: The company's stock price surged 93.2% over the past year, significantly outperforming the S&P 500, indicating an increasing competitive edge in the women's intimate apparel and beauty products sector, which is likely to continue attracting investor interest.
See More
Wall Street's First Trading Day of March Outlook
- Middle East Impact: The U.S.-Israeli attack on Iran is likely to ripple through financial markets, with oil prices rising due to geopolitical risk premiums, as Brent crude has surged from the low $60s to around $73, indicating potential for further volatility.
- CrowdStrike Earnings Preview: CrowdStrike is set to report its quarterly results after Tuesday's close, with Wall Street expecting fiscal 2026 Q4 revenue of $1.3 billion and EPS of $1.10, providing CEO George Kurtz an opportunity to highlight the cybersecurity sector's unique position amidst AI disruption fears.
- Broadcom Earnings Expectations: Broadcom will release its earnings on Wednesday, with anticipated fiscal 2026 Q1 revenue of $19.14 billion and EPS of $2.02, as market sentiment remains optimistic about AI chip demand despite concerns over potential disruptions to infrastructure software.
- Costco Quarterly Report: Costco is expected to report its fiscal 2026 Q2 results after Thursday's close, with projected revenue of $69.22 billion and EPS of $4.56, as management will address consumer spending trends and membership renewal rates amid high price pressures.
See More
DME Capital Reduces Stake in Victoria's Secret
- Share Reduction Details: According to an SEC filing dated February 17, 2026, DME Capital reduced its stake in Victoria's Secret by 194,593 shares during Q4 2025, with an estimated transaction value of $7.73 million, indicating a strategy to realize profits amid rising stock prices.
- Value Change in Holdings: Despite the reduction, Victoria's Secret still represented 3.3% of DME Capital's assets, with the stake's value increasing by $41.69 million due to trading activity and price performance, reflecting the company's strong market position.
- Performance Metrics: As of February 17, 2026, shares of Victoria's Secret were priced at $60.36, marking a 93.2% increase over the past year, significantly outperforming the S&P 500 by 71.94 percentage points, showcasing robust growth in the competitive women's apparel market.
- Future Outlook: Victoria's Secret reported $1.5 billion in sales for Q3 2025, a 9% year-over-year increase, and raised its full-year guidance to $6.5 billion, indicating continued growth potential, although the current price-to-earnings ratio exceeding 30 may affect investors' buying decisions.
See More
DME Capital Reduces Stake in Victoria's Secret
- Share Reduction Transaction: DME Capital sold 194,593 shares of Victoria's Secret in Q4 2025, with an estimated trade value of $7.73 million, reflecting the fund's strategy to realize profits following a stock price increase.
- Holding Value Growth: As of December 31, 2025, the value of DME Capital's stake in Victoria's Secret increased by $41.69 million, indicating the dual impact of trading activity and price performance, although the stock now represents 3.3% of the fund's assets.
- Performance Exceeds Expectations: Victoria's Secret reported $1.5 billion in sales for its fiscal Q3, a 9% year-over-year increase, and raised its full-year guidance to $6.5 billion, further driving the stock price upward.
- Market Performance Analysis: The stock price of Victoria's Secret surged by 93.2% over the past year, reaching a 52-week high of $66.89 on January 9, 2026, demonstrating its strong performance in the highly competitive women's apparel market.
See More
Market Strategist Highlights Key Stock Picks
- Victoria's Secret Outlook: Market strategist highlights Victoria's Secret (VSCO) as performing well in the current bullish trend, with support at $55 to $58; if it breaks through recent highs of $62 to $63, it could reach new all-time highs, indicating strong potential driven by consumer confidence and diet drugs.
- Novo Nordisk Competitive Pressure: Novo Nordisk (NVO) faces competition from other pharmaceutical companies, and while its stock is under pressure around $47.73, analysts believe that if it can rebound to $50 to $52, the bottom support will appear solid, maintaining a long-term bullish outlook.
- BitMine Market Opportunity: BitMine (BMNR) is viewed as a stock play on cryptocurrency, with analysts optimistic about Ethereum's prospects, considering it undervalued; if it can hold around $1,900 and break above $2,000, significant upside potential may arise.
- Cryptocurrency Volatility: Despite recent volatility in the crypto market, analysts note that Ethereum's stability is improving, and sustained buying interest could make BMNR a key asset in their portfolio, reflecting confidence in the future of the crypto market.
See More
Trump Aims to Reinforce Tariffs Following Court Loss: Implications for the Economy and Investors.
Market Reaction: Stocks experienced a rally on Friday following the Supreme Court's rejection of a key aspect of President Trump's trade policy.
Future Outlook: Despite the initial market relief, investors are advised to brace for upcoming economic uncertainties.
See More
Seldon Capital Acquires Stake in Victoria's Secret & Co.
- New Investment Disclosure: Seldon Capital disclosed the acquisition of 155,950 shares of Victoria's Secret in Q4 2025, amounting to approximately $8.45 million, marking a new investment that reflects confidence in the brand's future growth potential.
- Significant Stake: This acquisition gives Seldon Capital a 2.92% stake in Victoria's Secret, representing a notable position within its reportable U.S. equity AUM, indicating a bullish outlook on the consumer goods sector.
- Performance Rebound: Victoria's Secret recently reported Q3 net sales of $1.472 billion, up 9% year-over-year, with management raising full-year sales guidance to $6.48 billion, showcasing strong performance amid market recovery.
- Enhanced Market Competitiveness: The company's stock price surged 93.2% over the past year, significantly outperforming the S&P 500, indicating an increasing competitive edge in the women's intimate apparel and beauty products sector, which is likely to continue attracting investor interest.
See More
